(Helmholtz Zentrum München – German Research Center for Environmental Health) Translational stem cell research for type 1 diabetes therapy is in prime focus with a new strategic alliance between the Novo Nordisk Foundation Center for Stem Cell Biology (DanStem) at the University of Copenhagen and Helmholtz Zentrum München — German Research Center for Environmental Health.
